ARTICLE | Clinical News
Apatinib: Ph III ANGEL started
March 15, 2017 7:51 PM UTC
LSK began the double-blind, placebo-controlled, international Phase III ANGEL trial to compare oral apatinib daily plus best supportive care (BSC) vs. BSC alone in about 459 patients who have failed ≥...